The Scientist

» drug development, microbiology and immunology

Most Recent

image: Who Is Immune to Zika?

Who Is Immune to Zika?

By | October 11, 2016

Researchers tap into ongoing dengue studies to improve antibody-based diagnostic tests for Zika and address unanswered questions about the emerging virus’s epidemiology.

4 Comments

image: Study: Enriched Housing Changes Murine T Cells

Study: Enriched Housing Changes Murine T Cells

By | October 3, 2016

Mice that live in a more-stimulating environment for two weeks appear to develop a more-inflammatory immune state that might help protect the animals against infection. 

0 Comments

image: Pet Meds Adapted from Human Therapies

Pet Meds Adapted from Human Therapies

By | October 1, 2016

Companies focused on developing treatments for dogs, cats, and horses are bringing a diverse array of products to the pet medicine market.

0 Comments

image: Saving Jon

Saving Jon

By | October 1, 2016

Meet the researcher/entrepreneur who started a nonprofit that seeks to solve the science behind a rare disease that threatens the life of her younger brother.

0 Comments

image: Bacteria and Humans Have Been Swapping DNA for Millennia

Bacteria and Humans Have Been Swapping DNA for Millennia

By | October 1, 2016

Bacteria inhabit most tissues in the human body, and genes from some of these microbes have made their way to the human genome. Could this genetic transfer contribute to diseases such as cancer?

3 Comments

image: Q&A: From FDA to Industry

Q&A: From FDA to Industry

By | September 27, 2016

Among a subset of US Food and Drug Administration regulators who leave the agency, more than half go to work for pharmaceutical companies, researchers report.

1 Comment

image: Life Scientists Receive “Genius” Grants

Life Scientists Receive “Genius” Grants

By | September 22, 2016

Among this year’s 23 MacArthur Foundation Fellows are pioneering biologists.

0 Comments

image: Allergan’s Buying Spree Rolls On

Allergan’s Buying Spree Rolls On

By | September 21, 2016

The Ireland-based pharma company makes a $1.7 billion offer to acquire Tobira Therapeutics, a US firm developing liver disease drugs.

0 Comments

image: Further Support for Early-Life Allergen Exposure

Further Support for Early-Life Allergen Exposure

By | September 20, 2016

Egg and peanut consumption during infancy is linked to lower risk of allergy to those foods later in life, according to a meta-analysis.

0 Comments

image: Feds Demand More Clinical Trial Reporting

Feds Demand More Clinical Trial Reporting

By | September 19, 2016

Expanded US Health and Human Services rules will require the results of more human studies to be made public.

1 Comment

Popular Now

  1. A Coral to Outlast Climate Change
  2. Science Celebrities: Where Are the Women?
  3. First In Vivo Human Genome Editing to Be Tested in New Clinical Trial
  4. Understanding Body Ownership and Agency
AAAS